Sources | Names Used |
---|---|
GDSC1000 | MPS-1-IN-1 |
PharmacoGx | MPS-1-IN-1 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GORASP2 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
mRNA | CCNL1 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
mRNA | FLVCR1 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
mRNA | HEMGN | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
mRNA | FBXL4 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.02 |
mRNA | HAPLN2 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.02 |
mRNA | NTPCR | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
mRNA | BAD | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
mRNA | MRPS25 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.02 |
mRNA | KIAA0753 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.02 |